| 7521456 |
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate |
Douglas J. M. Allen, Jeffrey W. Raggon, Dinos P. Santafianos, Ravi M. Shanker |
2009-04-21 |
| 7087613 |
Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride |
Jeffrey W. Raggon, Richard Connell, James D. Moyer, Michael John MORIN, Shama Kajiji +3 more |
2006-08-08 |
| 7019009 |
Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity |
Roberto Colon-Cruz |
2006-03-28 |
| 6900221 |
Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
Jeffrey W. Raggon, Richard Connell, James D. Moyer, Michael John MORIN, Shama Kajiji +3 more |
2005-05-31 |
| 6753334 |
Preparation of sodium-hydrogen exchanger type-1 inhibitors |
John F. Lambert |
2004-06-22 |
| 6706721 |
N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate |
Douglas J. M. Allen, Jeffrey W. Raggon, Dinos P. Santafianos, Ravi M. Shanker |
2004-03-16 |
| 6476040 |
Processes and intermediates for preparing anti-cancer compounds |
Dinos P. Santafianos, Richard S. Lehner |
2002-11-05 |
| 6359137 |
Process for preparing trovafloxacin acid salts |
Keith M. DeVries, Peter R. Rose |
2002-03-19 |
| 6346624 |
Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
Megan E. Hnatow, John F. Lambert |
2002-02-12 |
| 6344563 |
Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
Megan E. Hnatow, John F. Lambert |
2002-02-05 |
| 6262067 |
Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions |
Douglas J. M. Allen, Troy Anthony Appleton, Michael Gumkowski, David Joseph Muehlbauer |
2001-07-17 |
| 6239285 |
Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
Megan E. Hnatow |
2001-05-29 |
| 6159976 |
Polymorph of zopolrestat monohydrate |
John F. Lambert |
2000-12-12 |
| 6114531 |
Process for preparing quinolone and naphthyridone carboxylic acids |
— |
2000-09-05 |
| 6080756 |
Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin |
James McGarry, Douglas J. M. Allen |
2000-06-27 |
| 6066647 |
Zwitterionic forms of trovafloxacin |
Allen J. M. Douglas, David B. Joseph |
2000-05-23 |
| 5929240 |
Process and intermediates for preparing naphthyridonecarboxylic acid salts |
Tamim F. Braish, Darrell E. Fox, Peter R. Rose |
1999-07-27 |
| 5763454 |
Crystal form of anhydrous 7-(1.alpha.,5.alpha.,6.alpha.!-6-amino-3-azabicyclo3.1.0!hex-3-yl)-6-f luoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt |
Lynne A. Handanyan, Thomas A. Morris, Robert L. Hendrickson, Phillip J. Johnson |
1998-06-09 |
